According to Researchmoz, the global hip and knee orthopedic surgical robots market is expected to grow to $4.6 billion by 2022.
Here are five insights:
1. When knee and hip surgical robots are used, patients have less bleeding, reduction of postoperative pain, fewer readmissions to the hospital and faster recovery.
2. Stryker is one of the leading suppliers of orthopedic surgical robots after acquiring the Mako surgical robot in 2015. In addition, the ability to include a Mako total knee application with Stryker Triathlon total knee system is anticipated to increase market share of Stryker.
3. The aging U.S. population is increasing the demand for more precise total joint replacements, and sales industry profit margins have increased considerably during the past five years.
4. Surgical roboticists are increasingly being hired by Global 2000 organizations to link mobile robots into existing IT systems.
5. Hip and knee orthopedic surgical robot device markets were worth $84 million in 2015.
More on devices and implants:
Customized vs. standard total knee replacement implants: 9 key notes
Customized TKA implants yield enhanced outcomes & lower average total costs: 6 observations
Zimmer Biomet closes out FDA Warning Letter on Zhejiang, China manufacturing facility: 3 takeaways